Run by ANDHealth.
ANDHealth+ supports digital health and medtech companies from Melbourne for up to 24 months, across a four-to-six-month risk-mitigation stage and a 14-to-18-month stage on clinical and commercial milestones. Funding is up to AU$5 million per SME, non-dilutive and tranched against agreed milestones under the MRFF BioMedTech Incubator stream; the programme states there are no equity requirements or IP transfer.
This programme has notes explaining its undisclosed figures, available in the full dataset.
Every figure above is taken from these pages, published by the programme or its parent organisation.
Compare all 2 ANDHealth programmes.
Last verified 2026-09-07.